TrialScientific reports2018

Sodium Reduction, miRNA Profiling and CVD Risk in Untreated Hypertensives: a Randomized, Double-Blind, Placebo-Controlled Trial.

Li Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.